Ignite Creation Date:
2024-05-06 @ 2:58 PM
Last Modification Date:
2024-10-26 @ 1:40 PM
Study NCT ID:
NCT04480086
Status:
TERMINATED
Last Update Posted:
2023-08-29
First Post:
2020-07-20
Brief Title:
Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants With Myelofibrosis
Sponsor:
AbbVie
Organization:
AbbVie